Stat5 assumes distinct functions in mammary gland development and mammary tumor formation

Frontiers in Bioscience

Volumn 17, Issue 4, 2012, Pages 1232-1250

  Vafaizadeh, Vida ^a   Klemmt, Petra A B ^b,c   Groner, Bernd ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b Institute for Cell Biology and Neuroscience   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Estrogen receptor; Gene function analysis; Lentiviral gene modification; Mammary fat pad transplantation; Mammary lineage commitment; Mammary stem cells; Organ reconstitution; Review; Stat3; Stat5

Indexed keywords

MUS; MUS MUSCULUS;

STAT5 PROTEIN;

ANIMAL; ARTICLE; GROWTH, DEVELOPMENT AND AGING; MOUSE; PHYSIOLOGY; UDDER;

ANIMALS; MAMMARY GLANDS, ANIMAL; MICE; STAT5 TRANSCRIPTION FACTOR;

EID: 84859251977     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3983     Document Type: Article

References (150)

1. AE Voytovich, YJ Topper: Hormone-dependent differentiation of immature mouse mammary gland in vitro. Science 158, 1326-7 (1967).
2. BG Wood, LL Washburn, AS Mukherjee, MR Banerjee: Hormonal regulation of lobulo-alveolar growth, functional differentiation and regression of whole mouse mammary gland in organ culture. J Endocrinol 65, 1-6 (1975).
3. BK Vonderhaar: Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo. J Cell Physiol 132, 581-4 (1987). (Pubitemid 18005486)
4. WG Juergens, FE Stockdale, YJ Topper, JJ Elias: Hormone-dependent differentiation of mammary gland in vitro. Proc Natl Acad Sci U S A 54, 629-34 (1965).
5. CW Daniel, GB Silberstein, P Strickland: Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47, 6052-7 (1987). (Pubitemid 18018753)
6. KS Korach, JF Couse, SW Curtis, TF Washburn, J Lindzey, KS Kimbro, EM Eddy, S Migliaccio, SM Snedeker, DB Lubahn, DW Schomberg, EP Smith: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51, 159-86; discussion 186-8 (1996). (Pubitemid 126476613)
7. WP Bocchinfuso, KS Korach: Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2, 323- 34 (1997).
8. JP Lydon, FJ DeMayo, CR Funk, SK Mani, AR Hughes, CA Montgomery, Jr G Shyamala, OM Conneely, BW O'Malley: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9, 2266- 78 (1995).
9. CJ Ormandy, A Camus, J Barra, D Damotte, B Lucas, H Buteau, M Edery, N Brousse, C Babinet, N Binart, PA Kelly: Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11, 167-78 (1997). (Pubitemid 27081894)
10. L Hennighausen, GW Robinson: Information networks in the mammary gland. Nat Rev Mol Cell Biol 6, 715-25 (2005). (Pubitemid 41742795)
11. H Kouros-Mehr, EM Slorach, MD Sternlicht, Z Werb: GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-55 (2006). (Pubitemid 44792255)
12. ML Asselin-Labat, KD Sutherland, H Barker, R Thomas, M Shackleton, NC Forrest, L Hartley, L Robb, FG Grosveld, J van der Wees, GJ Lindeman, JE Visvader: Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9, 201-9 (2007). (Pubitemid 46420863)
13. SR Oakes, MJ Naylor, ML Asselin-Labat, KD Blazek, M Gardiner-Garden, HN Hilton, M Kazlauskas, MA Pritchard, LA Chodosh, PL Pfeffer, GJ Lindeman, JE Visvader, CJ Ormandy: The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 22, 581-6 (2008). (Pubitemid 351342431)
14. N Li, S Singh, P Cherukuri, H Li, Z Yuan, LW Ellisen, B Wang, D Robbins, J DiRenzo: Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 26, 1253-64 (2008).
15. O Yalcin-Ozuysal, M Fiche, M Guitierrez, KU Wagner, W Raffoul, C Brisken: Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. Cell Death Differ 17, 1600-12 (2010).
16. V Gouon-Evans, ME Rothenberg, JW Pollard: Postnatal mammary gland development requires macrophages and eosinophils. Development 127, 2269-82 (2000). (Pubitemid 30386567)
17. JN Lilla, Z Werb: Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol 337, 124-33 (2010).
18. A Ucar, V Vafaizadeh, H Jarry, J Fiedler, PA Klemmt, T Thum, B Groner, K Chowdhury: miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 42, 1101-8 (2010).
19. C Brisken, S Park, T Vass, JP Lydon, BW O'Malley, RA Weinberg: A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 95, 5076-81 (1998). (Pubitemid 28208553)
20. C Brisken, A Heineman, T Chavarria, B Elenbaas, J Tan, SK Dey, JA McMahon, AP McMahon, RA Weinberg: Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14, 650-4 (2000). (Pubitemid 30176819)
21. AC Buser, EK Gass-Handel, SL Wyszomierski, W Doppler, SA Leonhardt, J Schaack, JM Rosen, H Watkin, SM Anderson, DP Edwards: Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol 21, 106- 25 (2007). (Pubitemid 46043298)
22. E Stocklin, M Wissler, F Gouilleux, B Groner: Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383, 726-8 (1996). (Pubitemid 26360650)
23. RS Chapman, PC Lourenco, E Tonner, DJ Flint, S Selbert, K Takeda, S Akira, AR Clarke, CJ Watson: Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13, 2604-16 (1999). (Pubitemid 29489651)
24. K Abell, CJ Watson: The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 4, 897-900 (2005). (Pubitemid 41359754)
25. PA Kreuzaler, AD Staniszewska, W Li, N Omidvar, B Kedjouar, J Turkson, V Poli, RA Flavell, RW Clarkson, CJ Watson: Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 13, 303-9 (2011).
26. CJ Watson, WT Khaled: Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 135, 995-1003 (2008). (Pubitemid 351578128)
27. CW Daniel, LJ Young, D Medina, KB DeOme: The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol 6, 95- 101 (1971).
28. JE Visvader, GH Smith: Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol 3, (2011).
29. M Shackleton, F Vaillant, KJ Simpson, J Stingl, GK Smyth, ML Asselin-Labat, L Wu, GJ Lindeman, JE Visvader: Generation of a functional mammary gland from a single stem cell. Nature 439, 84-8 (2006). (Pubitemid 43053633)
30. J Stingl, P Eirew, I Ricketson, M Shackleton, F Vaillant, D Choi, HI Li, CJ Eaves: Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-7 (2006). (Pubitemid 43292419)
31. C Brisken, S Duss: Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev 3, 147-56 (2007). (Pubitemid 350129717)
32. PA Joshi, HW Jackson, AG Beristain, MA Di Grappa, PA Mote, CL Clarke, J Stingl, PD Waterhouse, R Khokha: Progesterone induces adult mammary stem cell expansion. Nature 465, 803-7 (2010).
33. ML Asselin-Labat, F Vaillant, JM Sheridan, B Pal, D Wu, ER Simpson, H Yasuda, GK Smyth, TJ Martin, GJ Lindeman, JE Visvader: Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798- 802 (2010).
34. KE Sleeman, H Kendrick, D Robertson, CM Isacke, A Ashworth, MJ. Smalley: Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176, 19-26 (2007). (Pubitemid 46041676)
35. HL LaMarca, JM Rosen: Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res 9, 304 (2007).
36. G Farnie, RB Clarke: Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev 3, 169-75 (2007). (Pubitemid 350129719)
37. M Lupien, J Eeckhoute, CA Meyer, Q Wang, Y Zhang, W Li, JS Carroll, XS Liu, M Brown: FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-70 (2008). (Pubitemid 351391952)
38. JH Martens, AB Brinkman, F Simmer, KJ Francoijs, A Nebbioso, F Ferrara, L Altucci, HG Stunnenberg: PMLRARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell 17, 173-85.
39. W Li, BJ Ferguson, WT Khaled, M Tevendale, J Stingl, V Poli, T Rich, P Salomoni, CJ Watson: PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 106, 4725-30 (2009).
40. HL LaMarca, JM Rosen: Minireview: hormones and mammary cell fate-what will I become when I grow up? Endocrinology 149, 4317-21 (2008).
41. TN Seagroves, JP Lydon, RC Hovey, BK Vonderhaar, JM Rosen: C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 14, 359-68 (2000). (Pubitemid 32260528)
42. JA Wickenden, CJ Watson: Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Breast Cancer Res 12, 202 (2010).
43. RB Boxer, DB Stairs, KD Dugan, KL Notarfrancesco, CP Portocarrero, BA Keister, GK Belka, H Cho, JC Rathmell, CB Thompson, MJ Birnbaum, LA Chodosh: Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab 4, 475-90 (2006). (Pubitemid 44817350)
44. IG Maroulakou, W Oemler, SP Naber, I Klebba, C Kuperwasser, PN Tsichlis: Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol 217, 468-77 (2008).
45. BA Creamer, K Sakamoto, JW Schmidt, AA Triplett, R Moriggl, KU Wagner: Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol 30, 2957-70 (2010).
46. M Jankiewicz, B Groner, S Desrivieres: Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2. Mol Endocrinol 20, 2369-81 (2006). (Pubitemid 44496407)
47. NS Kim, HJ Kim, BK Koo, MC Kwon, YW Kim, Y Cho, Y Yokota, JM Penninger, YY Kong: Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol Cell Biol 26, 1002- 13 (2006). (Pubitemid 43146493)
48. C Brisken, A Ayyannan, C Nguyen, A Heineman, F Reinhardt, J Tan, SK Dey, GP Dotto, RA Weinberg: IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell 3, 877-87 (2002). (Pubitemid 35460787)
49. L Hennighausen, GW Robinson: Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 22, 711-21 (2008). (Pubitemid 351439101)
50. PM Siegel, WJ Muller: Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene 29, 2753-9.
51. S Feng, SE Jacobsen, W Reik: Epigenetic reprogramming in plant and animal development. Science 330, 622-627.
52. R Bonasio, S Tu, D Reinberg: Molecular signals of epigenetic states. Science 330, 612-616.
53. GS Stein, SK Zaidi, JL Stein, JB Lian, AJ van Wijnen, M Montecino, DW Young, A Javed, J Pratap, JY Choi, SA Ali, S Pande, MQ Hassan: Transcription-factor-mediated epigenetic control of cell fate and lineage commitment. Biochem Cell Biol 87, 1-6 (2009).
54. M Rijnkels, E Kabotyanski, MB Montazer-Torbati, CH Beauvais, Y Vassetzky, JM Rosen, E Devinoy: The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia 15, 85-100.
55. EB Kabotyanski, M Rijnkels, C Freeman-Zadrowski, AC Buser, DP Edwards, JM Rosen: Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem 284, 22815-22824 (2009).
56. R Xu, CM Nelson, JL Muschler, M Veiseh, BK Vonderhaar, MJ Bissell: Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function. J Cell Biol 184, 57-66 (2009).
57. N Bloushtain-Qimron, J Yao, EL Snyder, M Shipitsin, LL Campbell, SA Mani, M Hu, H Chen, V Ustyansky, JE Antosiewicz, P Argani, MK Halushka, JA Thomson, P Pharoah, A Porgador, S Sukumar, R Parsons, AL Richardson, MR Stampfer, RS Gelman, T Nikolskaya, Y Nikolsky, K Polyak: Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 105, 14076-14081 (2008).
58. JI Wu, J Lessard, GR Crabtree: Understanding the words of chromatin regulation. Cell 136, 200-206 (2009).
59. C Schindler, K Shuai, VR Prezioso, JE Darnell, Jr: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813 (1992).
60. D Yamaji, R Na, Y Feuermann, S Pechhold, W Chen, GW Robinson, L Hennighausen: Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 23, 2382-2387 (2009).
61. L Wei, A Laurence, JJ O'Shea: New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin Cell Dev Biol 19, 394-400 (2008).
62. JW Kornfeld, F Grebien, MA Kerenyi, K Friedbichler, B Kovacic, B Zankl, A Hoelbl, H Nivarti, H Beug, V Sexl, M Muller, L Kenner, EW Mullner, F Gouilleux, R Moriggl: The different functions of Stat5 and chromatin alteration through Stat5 proteins. Front Biosci 13, 6237-6254 (2008).
63. L Gu, P Vogiatzi, M Puhr, A Dagvadorj, J Lutz, A Ryder, S Addya, P Fortina, C Cooper, B Leiby, A Dasgupta, T Hyslop, L Bubendorf, K Alanen, T Mirtti, MT Nevalainen: Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer 17, 481-493.
64. WX Li: Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 18, 545-551 (2008).
65. J Yang, GR Stark: Roles of unphosphorylated STATs in signaling. Cell Res 18, 443-451 (2008). (Pubitemid 351498851)
66. DJ Gough, A Corlett, K Schlessinger, J Wegrzyn, AC Larner, DE Levy: Mitochondrial STAT3 supports Rasdependent oncogenic transformation. Science 324, 1713- 1716 (2009).
67. J Wegrzyn, R Potla, YJ Chwae, NB Sepuri, Q Zhang, T Koeck, M Derecka, K Szczepanek, M Szelag, A Gornicka, A Moh, S Moghaddas, Q Chen, S Bobbili, J Cichy, J Dulak, DP Baker, A Wolfman, D Stuehr, MO Hassan, XY Fu, N Avadhani, JI Drake, P Fawcett, EJ Lesnefsky, AC Larner: Function of mitochondrial Stat3 in cellular respiration, in Science. 2009. 793-797.
68. R Nyga, C Pecquet, N Harir, H Gu, I Dhennin-Duthille, A Regnier, V Gouilleux-Gruart, K Lassoued, F Gouilleux: Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochem J 390, 359-366 (2005). (Pubitemid 41192263)
69. M Schmitt-Ney, W Doppler, RK Ball, B Groner: Betacasein gene promoter activity is regulated by the hormonemediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol 11, 3745-3755 (1991). (Pubitemid 21895762)
70. H Wakao, M Schmitt-Ney, B Groner: Mammary glandspecific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa. J Biol Chem 267, 16365-16370 (1992).
71. F Gouilleux, H Wakao, M Mundt, B Groner: Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. Embo J 13, 4361-4369 (1994). (Pubitemid 24295208)
72. X Liu, GW Robinson, F Gouilleux, B Groner, L Hennighausen: Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci U S A 92, 8831-8835 (1995).
73. V Vafaizadeh, P Klemmt, C Brendel, K Weber, C Doebele, K Britt, M Grez, B Fehse, S Desrivieres, B Groner: Mammary epithelial reconstitution with genemodified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. Stem Cells 28, 928-938 (2010).
74. SR Oakes, RL Rogers, MJ Naylor, CJ Ormandy: Prolactin regulation of mammary gland development. J Mammary Gland Biol Neoplasia 13, 13-28 (2008).
75. V Goffin, B Bouchard, CJ Ormandy, E Weimann, F Ferrag, P Touraine, C Bole-Feysot, RA Maaskant, P Clement-Lacroix, M Edery, N Binart, PA Kelly: Prolactin: a hormone at the crossroads of neuroimmunoendocrinology. Ann N Y Acad Sci 840, 498- 509 (1998). (Pubitemid 28302075)
76. R Das, BK Vonderhaar: Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 40, 141-149 (1996). (Pubitemid 26283507)
77. RA Erwin, RA Kirken, MG Malabarba, WL Farrar, H Rui: Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 136, 3512-3518 (1995).
78. JA Fresno Vara, MA Caceres, A Silva, J Martin-Perez: Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell 12, 2171-2183 (2001). (Pubitemid 33049707)
79. C Tessier, A Prigent-Tessier, S Ferguson-Gottschall, Y Gu, G Gibori: PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 142, 4086-4094 (2001). (Pubitemid 32802681)
80. CV Clevenger, W Ngo, DL Sokol, SM Luger, AM Gewirtz: Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 270, 13246-13253 (1995).
81. N Tourkine, C Schindler, M Larose, LM Houdebine: Activation of STAT factors by prolactin, interferongamma, growth hormones, and a tyrosine phosphatase inhibitor in rabbit primary mammary epithelial cells. J Biol Chem 270, 20952-20961 (1995).
82. M David, L Wong, R Flavell, SA Thompson, A Wells, AC Larner, GR Johnson: STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem 271, 9185- 9188 (1996).
83. MI Gallego, N Binart, GW Robinson, R Okagaki, KT Coschigano, J Perry, JJ Kopchick, T Oka, PA Kelly, L Hennighausen: Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229, 163-175 (2001). (Pubitemid 32061721)
84. GJ Lindeman, S Wittlin, H Lada, MJ Naylor, M Santamaria, JG. Zhang, R Starr, DJ Hilton, WS Alexander, CJ Ormandy, J Visvader: SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev 15, 1631-1636 (2001). (Pubitemid 32702585)
85. J Harris, PM Stanford, K Sutherland, SR Oakes, MJ Naylor, FG Robertson, KD Blazek, M Kazlauskas, HN Hilton, S Wittlin, WS Alexander, GJ Lindeman, JE Visvader, CJ Ormandy: Socs2 and elf5 mediate prolactininduced mammary gland development. Mol Endocrinol 20, 1177-1187 (2006).
86. ME Freeman, MS Smith, SJ Nazian, JD Neill: Ovarian and hypothalamic control of the daily surges of prolactin secretion during pseudopregnancy in the rat. Endocrinology 94, 875-882 (1974).
87. B Howard, A Ashworth: Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet 2, e112 (2006).
88. WA Woodward, MS Chen, F Behbod, JM Rosen: On mammary stem cells. J Cell Sci 118, 3585-3594 (2005). (Pubitemid 41309406)
89. T Vargo-Gogola, JM Rosen: Modelling breast 1cancer: one size does not fit all. Nat Rev Cancer 7, 659- 672 (2007). (Pubitemid 47327411)
90. GW Robinson, L Hennighausen: MMTV-Cre transgenes can adversely affect lactation: Considerations for conditional gene deletion in mammary tissue. Anal Biochem 412, 92-95 (2011).
91. KU Wagner, K McAllister, T Ward, B Davis, R Wiseman, L Hennighausen: Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10, 545-553 (2001). (Pubitemid 34043179)
92. KU Wagner, RJ Wall, L St-Onge, P Gruss, A Wynshaw-Boris, L Garrett, M Li, PA Furth, L Hennighausen: Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25, 4323-4330 (1997). (Pubitemid 27485212)
93. H Niwa, T Burdon, I Chambers, A Smith: Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12, 2048-2060 (1998). (Pubitemid 28323878)
94. SH Tan, MT Nevalainen: Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer 15, 367-390 (2008). (Pubitemid 351880829)
95. V Hwa, B Little, P Adiyaman, EM Kofoed, KL Pratt, G Ocal, M Berberoglu, RG Rosenfeld: Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 90, 4260-4266 (2005). (Pubitemid 41058207)
96. EM Kofoed, V Hwa, B Little, KA Woods, CK Buckway, J Tsubaki, KL Pratt, L Bezrodnik, H Jasper, A Tepper, JJ Heinrich, RG Rosenfeld: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349, 1139-1147 (2003). (Pubitemid 37122326)
97. S Vidarsdottir, MJ Walenkamp, AM Pereira, M Karperien, J van Doorn, HA van Duyvenvoorde, S White, MH Breuning, F Roelfsema, MF Kruithof, J van Dissel, R Janssen, JM Wit, JA Romijn: Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab 91, 3482-3485 (2006). (Pubitemid 44402123)
98. X Liu, GW Robinson, KU Wagner, L Garrett, A Wynshaw-Boris, L Hennighausen: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11, 179-186 (1997). (Pubitemid 27081895)
99. GB Udy, RP Towers, RG Snell, RJ Wilkins, SH Park, PA Ram, DJ Waxman, HW Davey: Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94, 7239- 7244 (1997). (Pubitemid 27345299)
100. S Teglund, C McKay, E Schuetz, JM van Deursen, D Stravopodis, D Wang, M Brown, S Bodner, G Grosveld, JN Ihle: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850 (1998). (Pubitemid 28257589)
101. M Socolovsky, AE Fallon, S Wang, C Brugnara, HF Lodish: Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98, 181-191 (1999).
102. Y Cui, G Riedlinger, K Miyoshi, W Tang, C Li, CX Deng, GW Robinson, L Hennighausen: Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24, 8037-8047 (2004). (Pubitemid 39167454)
103. BM Zhu, SK McLaughlin, R Na, J Liu, Y Cui, C Martin, A Kimura, GW Robinson, NC Andrews, L Hennighausen: Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood 112, 2071-2080 (2008).
104. K Miyoshi, JM Shillingford, GH Smith, SL Grimm, KU Wagner, T Oka, JM Rosen, GW Robinson, L Hennighausen: Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155, 531-542 (2001). (Pubitemid 34289312)
105. OW Petersen, K. Polyak: Stem cells in the human breast. Cold Spring Harb Perspect Biol 2, a003160.
106. C Ginestier, MH Hur, E Charafe-Jauffret, F Monville, J Dutcher, M Brown, J Jacquemier, P Viens, CG Kleer, S Liu, A Schott, D Hayes, D Birnbaum, MS Wicha, G Dontu: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007). (Pubitemid 350056407)
107. M Diehn, RW Cho, NA Lobo, T Kalisky, MJ Dorie, AN Kulp, D Qian, JS Lam, LE Ailles, M Wong, B Joshua, MJ Kaplan, I Wapnir, FM Dirbas, G Somlo, C Garberoglio, B Paz, J Shen, SK Lau, SR Quake, JM Brown, IL Weissman, MF Clarke: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783 (2009).
108. M Al-Hajj, MS Wicha, A Benito-Hernandez, SJ Morrison, MF Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988 (2003). (Pubitemid 36418143)
109. CC Chang, W Sun, A Cruz, M Saitoh, MH Tai, JE Trosko: A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Radiat Res 155, 201-207 (2001). (Pubitemid 33723539)
110. C.C. Chang: Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res 8, 103 (2006).
111. M Demaria, C Giorgi, M Lebiedzinska, G Esposito, L D'Angeli, A Bartoli, DJ Gough, J Turkson, DE Levy, CJ Watson, MR Wieckowski, P Provero, P Pinton, V Poli: A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging (Albany NY) 2, 823-842 (2010).
112. NE Hynes, CJ Watson: Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb Perspect Biol 2, a003186.
113. CJ Watson: Stat transcription factors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 6, 115-127 (2001). (Pubitemid 33640650)
114. KU Wagner, H Rui: Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. JMammary Gland Biol Neoplasia 13, 93-103 (2008).
115. I Cotarla, S Ren, Y Zhang, E Gehan, B Singh, PA Furth: Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 108, 665-671 (2004). (Pubitemid 38076397)
116. A Prat, J Baselga: The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat Clin Pract Oncol 5, 531- 542 (2008).
117. C Borghouts, H Tittmann, N Delis, M Kirchenbauer, B Brill, B Groner: The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death. Mol Cancer Res 8, 539-553.
118. MA Dawson, AJ Bannister, B Gottgens, SD Foster, T Bartke, AR Green, T Kouzarides: JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 461, 819-822 (2009).
119. E Iavnilovitch, B Groner, I Barash: Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 1, 32-47 (2002). (Pubitemid 36330209)
120. K Yamada, K Ariyoshi, M Onishi, A Miyajima, F Hayakawa, M Towatari, H Saito, Y Oka, S Asano, T Nosaka, T Kitamura: Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis. Int J Hematol 71, 46-54 (2000).
121. M Onishi, T Nosaka, K Misawa, AL Mui, D Gorman, M McMahon, A Miyajima, T Kitamura: Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18, 3871- 3879 (1998). (Pubitemid 28287910)
122. K Ariyoshi, T Nosaka, K Yamada, M Onishi, Y Oka, A Miyajima, T Kitamura: Constitutive activation of STAT5 by a point mutation in the SH2 domain. J Biol Chem 275, 24407-24413 (2000). (Pubitemid 30626531)
123. R Moriggl, V Sexl, L Kenner, C Duntsch, K Stangl, S Gingras, A Hoffmeyer, A Bauer, R Piekorz, D Wang, KD Bunting, EF Wagner, K Sonneck, P Valent, JN Ihle, H Beug: Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7, 87-99 (2005). (Pubitemid 40126385)
124. PM Grimley, F Dong, H Rui: Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 10, 131-157 (1999). (Pubitemid 29446377)
125. S Berchtold, R Moriggl, F Gouilleux, O Silvennoinen, C Beisenherz, E Pfitzner, M Wissler, E Stocklin, B Groner: Cytokine receptor-independent, constitutively active variants of STAT5. J Biol Chem 272, 30237-30243 (1997). (Pubitemid 27512227)
126. T Nosaka, T Kawashima, K Misawa, K Ikuta, AL Mui, T Kitamura: STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. Embo J 18, 4754-4765 (1999). (Pubitemid 29415529)
127. L Shan, M Yu, BD Clark, EG Snyderwine: Possible role of Stat5a in rat mammary gland carcinogenesis. Breast Cancer Res Treat 88, 263-272 (2004). (Pubitemid 40137305)
128. RC Humphreys, L Hennighausen: Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 19, 1085-1091 (2000). (Pubitemid 30153794)
129. S Ren, HR Cai, M Li, PA Furth: Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 21, 4335-4339 (2002). (Pubitemid 34753841)
130. T Eilon, B Groner, I Barash: Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females. Int J Cancer 121, 1892-1902 (2007). (Pubitemid 47463151)
131. E Iavnilovitch, RD Cardiff, B Groner, I Barash: Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer 112, 607-619 (2004). (Pubitemid 39425940)
132. JF Mahler, W Stokes, PC Mann, M Takaoka, RR Maronpot: Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24, 710-716 (1996). (Pubitemid 27029916)
133. AI Nieto, G Shyamala, JJ Galvez, G Thordarson, LM Wakefield, RD Cardiff: Persistent mammary hyperplasia in FVB/N mice. Comp Med 53, 433-438 (2003). (Pubitemid 37129303)
134. LM Wakefield, G Thordarson, AI Nieto, G Shyamala, JJ Galvez, MR Anver, RD Cardiff: Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 53, 424-432 (2003). (Pubitemid 37129302)
135. AC Andres, MA van der Valk, CA Schonenberger, F Fluckiger, M LeMeur, P Gerlinger, B Groner: Ha-ras and cmyc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev 2, 1486- 1495 (1988).
136. DW Felsher: Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Cancer Res 68, 3081-3086; discussion 3086 (2008).
137. J Ferlay, P Autier, M Boniol, M Heanue, M Colombet, P Boyle: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18, 581-592 (2007). (Pubitemid 46359643)
138. H Yamashita, H Iwase, T Toyama, Y Fujii: Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene 22, 1638- 1652 (2003). (Pubitemid 36408179)
139. H Yamashita, M Nishio, Y Ando, Z Zhang, M Hamaguchi, K Mita, S Kobayashi, Y Fujii, H Iwase: Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr Relat Cancer 13, 885-893 (2006). (Pubitemid 44763264)
140. J Russo, X Ao, C Grill, IH Russo: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53, 217-227 (1999). (Pubitemid 29209891)
141. H Kendrick, JL Regan, FA Magnay, A Grigoriadis, C Mitsopoulos, M Zvelebil, MJ Smalley: Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9, 591 (2008).
142. S Mallepell, A Krust, P Chambon, C Brisken: Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A 103, 2196-2201 (2006). (Pubitemid 43271646)
143. SL Grimm, JM Rosen: Stop! In the name of transforming growth factor-beta:
144. KU Wagner, CA Boulanger, MD Henry, M Sgagias, L Hennighausen, GH Smith: An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129, 1377- 1386 (2002). (Pubitemid 34874159)
145. MD Henry, AA Triplett, KB Oh, GH Smith, KU Wagner: Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23, 6980-6985 (2004). (Pubitemid 39279998)
146. H Yu, D Pardoll, R Jove: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9, 798-809 (2009).
147. SR Walker, EA Nelson, L Zou, M Chaudhury, S Signoretti, A Richardson, DA Frank: Reciprocal effects of STAT5 and STAT3 in breast cancer. Mol Cancer Res 7, 966-976 (2009).
148. P Schedin: Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6, 281-291 (2006).
149. R Fernandez-Valdivia, A Mukherjee, Y Ying, J Li, M Paquet, FJ DeMayo, JP Lydon: The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 328, 127-139 (2009).
150. S Ali, RC Coombes: Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2, 101-112 (2002). (Pubitemid 37328797)